Infusystem Share Price (NYSE: INFU)

$9.81

▲

-0.06

(-0.61%)

Live

Last updated on August 27, 2025 at 12:37 AM IST

$₹

Check the interactive Infusystem Stock chart to analyse performance

Infusystem stock performance

as on August 27, 2025 at 12:37 AM IST

Today's Low:$9.72
Today's High:$10.10
$9.81
0.92%
Downside
Day's Volatility :3.76%
Upside
2.87%
52 Weeks Low:$4.61
52 Weeks High:$9.97
$9.81
53.01%
Downside
52 Weeks Volatility :53.76%
Upside
1.6%

Infusystem Stock Returns

Period	Infusystem Holdings Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	90.17%	4.5%	0.0%
6 Months	26.21%	-7.9%	0.0%
1 Year	53.26%	-12.3%	0.0%
3 Years	30.56%	7.0%	-6.9%

Infusystem Holdings Inc Key Stats

Check Infusystem key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$9.87
Open	$9.585
Today's High	$10.1
Today's Low	$9.72
Market Capitalization	$201.6M
Today's Volume	$276.2K
52 Week High	$10.1
52 Week Low	$4.61
Revenue TTM	$139.9M
EBITDA	$24.4M
Earnings Per Share (EPS)	$0.24
PE Ratio	41.13
Profit Margin	3.63%
Quarterly Earnings Growth YOY	3.0%
Return On Equity TTM	9.39%

Stock Returns calculator for Infusystem Stock including INR - Dollar returns

The Infusystem stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Infusystem investment value today

Current value as on today

₹1,56,857

Returns

₹56,857

(+56.86%)

Returns from Infusystem Stock

₹52,329 (+52.33%)

Dollar Returns*

₹4,527 (+4.53%)

Indian investors sentiment towards Infusystem Stock

Period: Jul 26, 2025 to Aug 25, 2025. Change in 30 Days versus previous period

Search interest for Infusystem Stock from India on INDmoney has increased by 6% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Infusystem Stock

Rating

Trend

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Infusystem(by analysts ranked 0 to 5 stars)

Infusystem Share Price Target

What analysts predicted

Upside of 40.16%

Target:

$13.75

Current:

$9.81

Infusystem share price target is $13.75, a slight Upside of 40.16% compared to current price of $9.81 as per analysts' prediction.

Infusystem Stock Insights

Price Movement
In the last 1 month, INFU stock has moved up by 64.2%
Increasing Revenue
Revenue is up for the last 3 quarters, 33.84M → 36.00M (in $), with an average increase of 3.0% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -267.0K → 2.59M (in $), with an average increase of 110.3% per quarter
INFU vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 29.2% return, outperforming this stock by 1.0%

Infusystem Holdings Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$81.1M	↑ 20.82%
Net Income	$1.4M	↓ 224.29%
Net Profit Margin	1.68%	↑ 3.31%

	FY20	Y/Y Change
Revenue	$97.4M	↑ 20.06%
Net Income	$17.3M	↑ 1173.48%
Net Profit Margin	17.8%	↑ 16.12%

	FY21	Y/Y Change
Revenue	$102.4M	↑ 5.13%
Net Income	$1.4M	↓ 91.81%
Net Profit Margin	1.39%	↓ 16.41%

	FY22	Y/Y Change
Revenue	$109.9M	↑ 7.36%
Net Income	$18.0K	↓ 98.73%
Net Profit Margin	0.02%	↓ 1.37%

	FY23	Y/Y Change
Revenue	$125.8M	↑ 14.44%
Net Income	$872.0K	↑ 4744.44%
Net Profit Margin	0.69%	↑ 0.67%

	FY24	Y/Y Change
Revenue	$134.9M	↑ 7.22%
Net Income	$2.3M	↑ 168.92%
Net Profit Margin	1.74%	↑ 1.05%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$32.0M	↑ 0.71%
Net Income	$-1.1M	↓ 1644.44%
Net Profit Margin	-3.48%	↓ 3.71%

	Q2 FY24	Q/Q Change
Revenue	$33.7M	↑ 5.32%
Net Income	$717.0K	↓ 164.48%
Net Profit Margin	2.13%	↑ 5.61%

	Q3 FY24	Q/Q Change
Revenue	$35.3M	↑ 4.81%
Net Income	$1.8M	↑ 152.02%
Net Profit Margin	5.12%	↑ 2.99%

	Q4 FY24	Q/Q Change
Revenue	$33.8M	↓ 4.17%
Net Income	$933.0K	↓ 48.37%
Net Profit Margin	2.76%	↓ 2.36%

	Q1 FY25	Q/Q Change
Revenue	$34.7M	↑ 2.56%
Net Income	$-267.0K	↓ 128.62%
Net Profit Margin	-0.77%	↓ 3.53%

	Q2 FY25	Q/Q Change
Revenue	$36.0M	↑ 3.7%
Net Income	$2.6M	↓ 1073.41%
Net Profit Margin	7.22%	↑ 7.99%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$46.9M	↑ 20.15%

	FY20	Y/Y Change
Profit	$58.8M	↑ 25.33%

	FY21	Y/Y Change
Profit	$60.2M	↑ 2.45%

	FY22	Y/Y Change
Profit	$62.6M	↑ 3.94%

	FY23	Y/Y Change
Profit	$63.1M	↑ 0.86%

	FY24	Y/Y Change
Profit	$70.4M	↑ 11.56%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$15.9M	↓ 3.27%

	Q2 FY24	Q/Q Change
Profit	$16.1M	↑ 1.22%

	Q3 FY24	Q/Q Change
Profit	$19.0M	↑ 18.14%

	Q4 FY24	Q/Q Change
Profit	$18.2M	↓ 4.35%

	Q1 FY25	Q/Q Change
Profit	$19.2M	↑ 5.22%

	Q2 FY25	Q/Q Change
Profit	$19.9M	↑ 3.69%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$13.9M	↑ 21.81%
Investing Cash Flow	$-19.6M	↑ 294.12%
Financing Cash Flow	$4.1M	↓ 173.71%

	FY20	Y/Y Change
Operating Cash Flow	$20.3M	↑ 46.16%
Investing Cash Flow	$-12.2M	↓ 38.08%
Financing Cash Flow	$-1.1M	↓ 127.26%

	FY21	Y/Y Change
Operating Cash Flow	$18.3M	↓ 9.68%
Investing Cash Flow	$-21.3M	↑ 75.26%
Financing Cash Flow	$-6.5M	↑ 478.6%

	FY22	Y/Y Change
Operating Cash Flow	$17.5M	↓ 4.36%
Investing Cash Flow	$-11.5M	↓ 46.15%
Financing Cash Flow	$-6.1M	↓ 6.24%

	FY23	Y/Y Change
Operating Cash Flow	$11.2M	↓ 35.93%
Investing Cash Flow	$-6.7M	↓ 41.33%
Financing Cash Flow	$-4.4M	↓ 27.01%

	FY24	Y/Y Change
Operating Cash Flow	$20.5M	↑ 82.3%
Investing Cash Flow	$-13.2M	↑ 96.6%
Financing Cash Flow	$-6.9M	↑ 56.55%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$377.0K	↓ 91.91%
Investing Cash Flow	$-418.0K	-
Financing Cash Flow	$632.0K	↓ 117.83%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$2.3M	↑ 512.47%
Investing Cash Flow	$-6.7M	↑ 1501.91%
Financing Cash Flow	$3.7M	↑ 487.18%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$9.8M	↑ 326.25%
Investing Cash Flow	$-2.9M	↓ 57.35%
Financing Cash Flow	$-6.8M	↓ 281.95%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$7.9M	↓ 19.42%
Investing Cash Flow	$-3.3M	↑ 14.46%
Financing Cash Flow	$-4.5M	↓ 33.13%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$1.8M	↓ 77.56%
Investing Cash Flow	$-2.7M	↓ 18.6%
Financing Cash Flow	$1.9M	↓ 141.2%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$7.0M	↑ 293.76%
Investing Cash Flow	$-1.7M	↓ 36.68%
Financing Cash Flow	$-6.1M	↓ 428.49%

Infusystem Technicals Summary

Sell

Neutral

Buy

Infusystem is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Infusystem Holdings Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Infusystem Holdings Inc	67.29%	26.21%	53.26%	30.56%	-28.17%
Intuitive Surgical, Inc.	-5.17%	-18.36%	-2.25%	124.23%	98.09%
Alcon Ag	-10.39%	-11.34%	-15.15%	22.56%	39.28%
West Pharmaceutical Services Inc	-4.1%	12.28%	-18.55%	-18.04%	-9.76%
Resmed Inc.	4.46%	20.96%	26.49%	29.49%	58.12%
Becton, Dickinson And Company	6.4%	-15.39%	-17.62%	-23.5%	-21.06%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Infusystem Holdings Inc	41.13	41.13	0.0	0.22	0.09	0.07	NA	2.67
Intuitive Surgical, Inc.	66.23	66.23	3.49	8.12	0.16	0.09	NA	49.79
Alcon Ag	37.97	37.97	2.23	3.09	0.05	0.03	0.0	44.73
West Pharmaceutical Services Inc	37.05	37.05	3.58	6.76	0.18	0.11	0.0	40.74
Resmed Inc.	30.85	30.85	1.98	9.5	0.26	0.14	0.01	40.77
Becton, Dickinson And Company	36.5	36.5	1.0	14.37	0.06	0.04	0.02	88.87

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Infusystem Holdings Inc	Buy	$201.6M	-28.17%	41.13	3.63%
Intuitive Surgical, Inc.	Buy	$170.7B	98.09%	66.23	28.51%
Alcon Ag	Buy	$40.6B	39.28%	37.97	10.7%
West Pharmaceutical Services Inc	Buy	$17.8B	-9.76%	37.05	16.48%
Resmed Inc.	Buy	$43.0B	58.12%	30.85	27.22%
Becton, Dickinson And Company	Buy	$57.2B	-21.06%	36.5	7.41%

About Infusystem Holdings Inc

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates in two segments, Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells and rents new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, the company offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

Organization	Infusystem
Employees	502
CEO	Ms. Carrie A. Lachance B.S.N., M.B.A., R.N.
Industry	Health Technology

Key Management of Infusystem Holdings Inc

Name	Title
Ms. Carrie A. Lachance B.S.N., M.B.A., R.N.	President, CEO & Director
Mr. Addam Chupa	Executive VP & Chief Information Officer
Mr. Jerod Funke	Executive VP & Chief HR Officer
Ms. Jeanie Latz	Corporate Secretary

Important FAQs about investing in INFU Stock from India :

What is Infusystem share price today?

Infusystem share price today is $9.81 as on August 27, 2025 at 12:37 AM IST. Infusystem share today touched a day high of $10.10 and a low of $9.72.

What is the 52 week high and 52 week low for Infusystem share?

Infusystem share touched a 52 week high of $9.97 and a 52 week low of $4.61. Infusystem stock price today i.e. August 27, 2025 at 12:37 AM IST is trending at $9.81, lower by 1.6% versus the 52 week high.

How to invest in Infusystem Stock (INFU) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Infusystem on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Infusystem Shares that will get you 0.1529 shares as per Infusystem share price of $9.81 per share as on August 27, 2025 at 12:37 AM IST.

What is the minimum amount required to buy Infusystem Stock (INFU) from India?

Indian investors can start investing in Infusystem (INFU) shares with as little as ₹87.6525 or $1 (as of August 26, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹876.53 in Infusystem stock (as per the Rupee-Dollar exchange rate as on August 26, 2025). Based on Infusystem share’s latest price of $9.81 as on August 27, 2025 at 12:37 AM IST, you will get 1.0194 shares of Infusystem. Learn more about fractional shares .

What are the returns that Infusystem has given to Indian investors in the last 5 years?

Infusystem stock has given -28.17% share price returns and 18.61% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?